Yoo Shin Hyuk, Kim Hyo-Yeon, Kim Yoon-Ah, Mo Ji-Hun
Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Republic of Korea.
Dankook Physician Scientist Research Center, Dankook University, Cheonan, Republic of Korea.
J Rhinol. 2023 Nov;30(3):149-154. doi: 10.18787/jr.2023.00056. Epub 2023 Nov 27.
Turbinoplasty may be an option in patients with persistent symptoms of allergic rhinitis (AR) despite adequate medication. The two most frequently used surgical techniques for turbinoplasty are radiofrequency ablation and microdebriderassisted turbinoplasty. This study compared the outcomes of these two surgical techniques and assessed the long-term treatment effects.
This study included patients with AR who underwent turbinoplasty between January 2010 and June 2017. We examined the medication scores, overall treatment satisfaction scores, and medical records. Based on the type of surgery, patients were classified into microdebrider and coblator groups. A telephone survey was conducted to collect data on the 5-year post-treatment efficacy parameters. Scores for allergic symptoms, prescription medicines taken after surgery, and general satisfaction were compared.
Of the total 241 patients, 192 (79.7%) and 49 (20.3%) underwent microdebrider-assisted turbinoplasty and radiofrequency ablation turbinoplasty, respectively. Both the microdebrider and coblator groups showed remarkable improvements in AR symptoms at the 5-year follow-up (p<0.001). Although the degree of symptom improvement did not differ significantly between the two groups, the coblator group did show significant improvements in medication scores when compared with the microdebrider group (p<0.05), and there were significant differences in postoperative satisfaction scores between the two groups.
In terms of 5-year postoperative outcomes, radiofrequency-ablation turbinoplasty and microdebrider-assisted turbinoplasty were equally beneficial for reducing nasal symptoms and enhancing medication ratings in patients with AR.
对于尽管药物治疗充分但仍有持续性变应性鼻炎（AR）症状的患者，鼻甲成形术可能是一种选择。鼻甲成形术最常用的两种手术技术是射频消融和微切吸辅助鼻甲成形术。本研究比较了这两种手术技术的效果，并评估了长期治疗效果。
本研究纳入了2010年1月至2017年6月期间接受鼻甲成形术的AR患者。我们检查了药物评分、总体治疗满意度评分和病历。根据手术类型，将患者分为微切吸组和双极射频组。进行电话调查以收集关于治疗后5年疗效参数的数据。比较了过敏症状评分、术后服用的处方药和总体满意度。
在总共241例患者中，分别有192例（79.7%）和49例（20.3%）接受了微切吸辅助鼻甲成形术和射频消融鼻甲成形术。在5年随访时，微切吸组和双极射频组的AR症状均有显著改善（p<0.001）。虽然两组症状改善程度无显著差异，但与微切吸组相比，双极射频组的药物评分有显著改善（p<0.05），且两组术后满意度评分有显著差异。
就术后5年的结果而言，射频消融鼻甲成形术和微切吸辅助鼻甲成形术在减轻AR患者的鼻部症状和提高药物评分方面同样有益。
